Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
Autor: | Donald Staines, Sonya Marshall-Gradisnik, Thao Nguyen, Simon Broadley, Teilah Kathryn Huth, Ekua Brenu, Sandra Bahia Ramos |
---|---|
Rok vydání: | 2015 |
Předmět: |
Adult
0301 basic medicine Multiple Sclerosis Encephalomyelitis Immunology Pilot Projects chemical and pharmacologic phenomena CD16 03 medical and health sciences Immune system medicine Chronic fatigue syndrome Humans Cytotoxic T cell Receptor Fatigue Syndrome Chronic biology business.industry Multiple sclerosis virus diseases hemic and immune systems General Medicine Middle Aged Flow Cytometry medicine.disease Lymphocyte Subsets Killer Cells Natural 030104 developmental biology Perforin biology.protein Female business |
Zdroj: | Scandinavian Journal of Immunology. 83:44-51 |
ISSN: | 1365-3083 0300-9475 |
Popis: | Patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and multiple sclerosis (MS) suffer from debilitating fatigue which is not alleviated by rest. In addition to the fatigue-related symptoms suffered by patients with CFS/ME and MS, dysfunction of the immune system and, in particular, reduced natural killer (NK) cell cytotoxic activity has also been reported in CFS/ME and MS. The purpose of this pilot study was to compare NK cellular mechanisms in patients with CFS/ME and MS to investigate potential dysfunctions in the NK cell activity pathway. Flow cytometry protocols assessed CD56(dim) CD16(+) and CD56(bright) CD16(+/-) NK cell expression of adhesion molecules, NK activating and inhibiting receptors, NK cell maturation and lytic proteins. All participants in this study were female and included 14 patients with CFS/ME, nine patients with MS and 19 non-fatigued controls. The patient groups and the non-fatigued controls were not taking any immunosuppressive or immune-enhancing medications. In the MS cohort, KIR2DL5 was significantly increased on CD56(bright) CD16(+/-) NK cells and expression of CD94 was significantly increased on CD56(dim) CD16(+) NK cells in comparison with the controls. Co-expression of CD57 and perforin was significantly increased on CD56(dim) CD16(+) NK cells from patients with CFS/ME compared to the MS and non-fatigued control participants. The results from this pilot study suggest that NK cells from patients with CFS/ME and MS may have undergone increased differentiation in response to external stimuli which may affect different mechanisms in the NK cell cytotoxic activity pathway. |
Databáze: | OpenAIRE |
Externí odkaz: |